Sun Pharma share price rises as Q2 results surpass street estimates; here's why brokerages are bullish on the stock
Sun Pharma shares rise after Q2 results beat estimates on profit and revenue front. Brokerages maintain 'buy' rating for Sun Pharma.
DNA News Desk
0
1
Sun Pharma shares rise after Q2 results beat estimates on profit and revenue front. Brokerages maintain 'buy' rating for Sun Pharma.
